This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Should I Do It? Symantec Bar Set Low

Symantec (SYMC - Get Report), best known for its Norton antivirus software, has seen its shares drop like a stone in 2007.

At Tuesday's closing price of $17.62, the stock is already down a quick 15.5% for the new year, as management hit investors with a disappointing fiscal third quarter (ended December) report Jan. 24.

The company also said Monday that it's buying systems management software producer Altiris (ATRS - Get Report) for $1.03 billion. While Symantec believes the purchase will be slightly accretive to fiscal 2008 (ending March) earnings, investors aren't soon to forget that the stock is down 19.4% since the company paid $10.2 billion for Veritas Software (VRTS - Get Report) in 2005.

Symantec is currently on track to see profits decline in fiscal 2007 for the first time in five years, to 96 cents a share. Even so, at 18.4 times full-year earnings, the company trades at a 43% discount to its historical average and a 14% discount to top competitor McAfee (MFE).

With that in mind, I'm here to answer investors' questions: Should I do it? Has Symantec dug itself a new hole with this acquisition, or has the stock already sold off too much?

The consumer security business still accounts for 30% of the company's business and grew 24% year over year in the latest quarter. But to keep up with declining storage sales, Symantec said last week that it will cut 5% of its workforce and reduce annual expenses by $200 million. Management also pledged to buy back $1 billion (57 million shares) of its stock over time. Even after the Altiris purchase, Symantec still has $2.2 billion ($2.30 a share) of cash on the balance sheet.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ATRS $1.08 0.00%
SYMC $19.76 0.00%
VRTS $85.68 0.00%
AAPL $94.02 0.00%
FB $104.07 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs